Amgen: Entry Into A Material Definitive Agreement, Results Of Operations And Financial Condition, Other Events, Financial Statements And Exhibits
January 30, 2023 U.S. Securities and Exchange Commission
Show full article |
This functionality is available for registred users only
|
Company — Amgen

-
Full nameAmgen, Inc.
-
Registration countryUSA
-
IndustryPharmaceutical Preparation and Biotechnology
Share